CVE-2024-24830: OpenObserve Privilege Escalation Vulnerability in Users API
Affected: openobserve · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 54% of scored CVEs
DescriptionCVE.org
OpenObserve is a observability platform built specifically for logs, metrics, traces, analytics, designed to work at petabyte scale. A vulnerability has been identified in the "/api/{org_id}/users" endpoint. This vulnerability allows any authenticated regular user ('member') to add new users with elevated privileges, including the 'root' role, to an organization. This issue circumvents the intended security controls for role assignments. The vulnerability resides in the user creation process, where the payload does not validate the user roles. A regular user can manipulate the payload to assign root-level privileges. This vulnerability leads to Unauthorized Privilege Escalation and significantly compromises the application's role-based access control system. It allows unauthorized control over application resources and poses a risk to data security. All users, particularly those in administrative roles, are impacted. This issue has been addressed in release version 0.8.0. Users are advised to upgrade. There are no known workarounds for this vulnerability.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- openobserve · openobserve< 0.8.0
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Vendor
- openobserve
- Published
- February 2024
CoverageNo articles yet
No CyberSIXT article names CVE-2024-24830 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.